Status:
COMPLETED
Study Evaluating Hot Flashes in Hormone Sensitive Breast Cancer
Lead Sponsor:
Institut Curie
Conditions:
Breast Cancer
Eligibility:
FEMALE
40-60 years
Brief Summary
The validation of the HFRDIS questionnaire in French will allow the use in common practice of this questionnaire in consultation in order to have a concrete and reproducible assessment of the impact o...
Detailed Description
The main objective is to assess the impact of hot flashes on the daily lives of patients on adjuvant hormone therapy for hormone-sensitive breast cancer. The primary test of judgment is composite. Th...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Control population:
- Patient aged 40 to 60 included.
- Patient with internet access and email address.
- Patient affiliated with a social security system, speaking and reading French.
- Collection of non-opposition to participation in the study.
- Hormone therapy for breast cancer
- Patient aged 40 to 60 included management for RH breast cancer under hormone therapy adjuvant therapy:
- Patient with internet access and email address.
- Patient affiliated with a social security system, speaking and reading French.
- Collection of consent to participate in the study.
- Exclusion criteria:
- Control population:
- Patient with a personal history of breast cancer.
- Patient with another cancer in the course of treatment.
- Woman with a life expectancy \< 6 months at the time of diagnosis (in relation to other serious chronic conditions).
- Persons deprived of their liberty or under guardianship.
- Inability to submit to the medical follow-up of the study for social or psychological reasons.
- Hormone therapy patients for breast cancer:
- Patient currently recurrent with breast cancer.
- Patient in metastatic breast cancer.
- Woman with a life expectancy \< 6 months at the time of diagnosis (in relation to other serious chronic conditions).
- Persons deprived of their liberty or under guardianship.
- Inability to submit to the medical follow-up of the trial for social or psychological reasons.
Exclusion
Key Trial Info
Start Date :
March 23 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 11 2022
Estimated Enrollment :
290 Patients enrolled
Trial Details
Trial ID
NCT04775043
Start Date
March 23 2021
End Date
April 11 2022
Last Update
August 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Curie
Saint-Cloud, France, 92110